MedPath

Effect of epinephrine on coroner bypass graft

Phase 3
Conditions
Coronary artery bypass graft.
Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris
I25.7
Registration Number
IRCT20200603047645N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
123
Inclusion Criteria

Non-emergency CABG candidate patients who have agreed to participate in the project
All patients with ASA class 3 and 4
All patients whose surgery duration is less than 6 hours

Exclusion Criteria

Patients who underwent emergency CABG surgery
Patients who do not have a consent to participate in the project
Patients who, in addition to CABG, are candidates for valve replacement surgery
Patients who had more than 6 hours of surgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding 24 hours after surgery. Timepoint: 24 hours after surgery. Method of measurement: Suction the amount of bleeding in the calibrated container.
Secondary Outcome Measures
NameTimeMethod
enght of stay at the ICU. Timepoint: When leaving the ICU. Method of measurement: Calculation from the date of surgery.;Patient's hemoglobin level after surgery. Timepoint: After surgery. Method of measurement: Complete Blood Count.
© Copyright 2025. All Rights Reserved by MedPath